TrademarkDir
BUILTPHORM
DEAD

Serial Number

86741923

Owner

BuiltPhorm, Inc.

Attorney

Christina M. Licursi

First Use Date

May 30, 2019

Filing Date

Aug 31, 2015

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

BUILTPHORM Trademark

Serial Number: 86741923 • Registration: 5874526

BUILTPHORM is a trademark filed by BuiltPhorm, Inc. on August 31, 2015. The trademark is classified under Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

BuiltPhorm, Inc. (2 trademarks)

PO Box 1267
Portsmouth, NH 03802

Entity Type: 03

Trademark Details

Filing Date

August 31, 2015

Registration Date

October 1, 2019

First Use Anywhere

May 30, 2019

First Use in Commerce

May 30, 2019

Published for Opposition

April 12, 2016

Cancellation Date

April 17, 2026

Goods & Services

Provision of intellectual property licensing services relating to images and photographs for use by others, which are provided through a database

Filing History

CANCELLED SEC. 8 (6-YR)
Apr 17, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 1, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 1, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 27, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 26, 2019 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 5, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 30, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 1, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jul 1, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 1, 2019 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 6, 2019 SUPC
USE AMENDMENT FILED
Jun 4, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 4, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 13, 2018 EXRA
SOU EXTENSION 5 GRANTED
Dec 12, 2018 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 12, 2018 AITU
SOU EXTENSION 5 FILED
Dec 4, 2018 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 4, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 6, 2018 EXRA
SOU EXTENSION 4 GRANTED
Jun 4, 2018 EX4G
SOU EXTENSION 4 FILED
Jun 4, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 4, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 5, 2017 EXRA
SOU EXTENSION 3 GRANTED
Dec 1, 2017 EX3G
SOU EXTENSION 3 FILED
Dec 1, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 1, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2017 EXRA
SOU EXTENSION 2 GRANTED
May 1, 2017 EX2G
SOU EXTENSION 2 FILED
May 1, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
May 1, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 3, 2016 EXRA
SOU EXTENSION 1 GRANTED
Dec 1, 2016 EX1G
SOU EXTENSION 1 FILED
Dec 1, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 1, 2016 EEXT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 13, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 13, 2016 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 7, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 12, 2016 NPUB
PUBLISHED FOR OPPOSITION
Apr 12, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 23, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 9, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 9, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 9, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 9, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 9, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2016 CRFA
ASSIGNED TO LIE
Feb 10, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 4, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 17, 2015 GNRN
NON-FINAL ACTION E-MAILED
Dec 17, 2015 GNRT
NON-FINAL ACTION WRITTEN
Dec 17, 2015 CNRT
ASSIGNED TO EXAMINER
Dec 10, 2015 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Sep 4, 2015 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 3, 2015 NWOS
NEW APPLICATION ENTERED
Sep 3, 2015 NWAP

Related Trademarks

More from this Owner

BUILT PHORM FOCUS YOUR DEVELOPMENT logo

BUILT PHORM FOCUS YOUR DEVELOPMENT

BUILT PHORM FOCUS YOUR DEVELOPMENT logo

BUILT PHORM FOCUS YOUR DEVELOPMENT

BUILT PHORM FOCUS YOUR DEVELOPMENT logo

BUILT PHORM FOCUS YOUR DEVELOPMENT